Key statistics
On Tuesday, Ligand Pharmaceuticals Inc (LGNXZ:PKC) closed at 0.004, 400.00% above the 52 week low of 0.0008 set on Apr 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0045 |
---|---|
High | 0.0045 |
Low | 0.004 |
Bid | -- |
Offer | -- |
Previous close | 0.004 |
Average volume | 8.47k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Oct 01 2024 19:23 BST.
More ▼
Press releases
- Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
- Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Ligand Reports Second Quarter 2024 Financial Results
- Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024